This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Merck Serono S. a.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Enrico D'Aniello: Innovator in Male Infertility Treatment
Introduction
Enrico D'Aniello is a notable inventor based in Sant'Antimo, Italy. He has made significant contributions to the field of male infertility treatment through his innovative research and patents. With a total of 2 patents, D'Aniello's work focuses on the use of specific amino acids to enhance male reproductive health.
Latest Patents
D'Aniello's latest patents include the use of a combination of D-aspartic and L-aspartic acids or their salts for the treatment of male infertility. This invention aims to stimulate procreative activity in men by increasing the number and motility of spermatozoa. The combination of these amino acids has shown promise in enhancing male fertility, making it a significant advancement in reproductive health.
Career Highlights
Enrico D'Aniello is currently associated with Merck Serono S.p.a., a leading biopharmaceutical company. His role at Merck Serono allows him to further his research and development efforts in the field of male infertility. D'Aniello's dedication to innovation has positioned him as a key figure in this important area of healthcare.
Collaborations
D'Aniello collaborates with his coworker, Salvatore D'Aniello, to advance their research initiatives. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in medical science.
Conclusion
Enrico D'Aniello's contributions to the treatment of male infertility through his patented inventions highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in reproductive health, benefiting many individuals seeking solutions to infertility challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
